Loading company…
Proto Axiom incubates biomedical technology companies and helps commercialize Australian scientific intellectual property.
Proto Axiom invests in biotechnology companies and supports the licensing and commercialization of Australian scientific intellectual property. Founded in 2021, the biomedical technology incubator is based in Melbourne, Australia. In April 2023, it raised USD 5 million in Series A funding from Churchill Asset Management and Riverlane Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in